NEUKIO BIOTHERAPEUTICS
Neukio Biotherapeutics is an immune cell drug developer, focusing on the research and development and industrialization of immune cell drugs, developing iPSC-CAR-NK general-purpose spot immune cell products, and is committed to providing effective therapeutic drugs for cancer patients around the world.
NEUKIO BIOTHERAPEUTICS
Industry:
Biotechnology
Founded:
2021-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Status:
Active
Total Funding:
90 M USD
Similar Organizations
ImmPACT Bio
ImmPACT Bio USA is developing novel cell therapies for treating cancer.
Current Employees Featured
Founder
Investors List
Yahui Precision Medicine Fund
Yahui Precision Medicine Fund investment in Series A - Neukio Biotherapeutics
Kuanyu Private Equity
Kuanyu Private Equity investment in Series A - Neukio Biotherapeutics
CD Capital
CD Capital investment in Series A - Neukio Biotherapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Series A - Neukio Biotherapeutics
Sherpa Venture Capital
Sherpa Venture Capital investment in Series A - Neukio Biotherapeutics
IDG Capital
IDG Capital investment in Series A - Neukio Biotherapeutics
Sherpa Venture Capital
Sherpa Venture Capital investment in Angel Round - Neukio Biotherapeutics
Lilly Asia Ventures
Lilly Asia Ventures investment in Angel Round - Neukio Biotherapeutics
IDG Capital
IDG Capital investment in Angel Round - Neukio Biotherapeutics